Prebona (PREBON) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
27 Aug, 2026Executive summary
Sales activity and commercial momentum increased in Q2 2026, with more qualified customer dialogues and new distributors, especially in the textile segment.
Regulatory trends and sustainability focus are driving demand for the company's technology, particularly as alternatives to silver-based textile treatments.
International expansion continues, with new orders and partnerships in South Korea, the Nordics, and the UK.
Healthcare segment is expanding, leveraging previous wins in Finland and Denmark, and planning further market activities.
Financial highlights
Net sales for H1 2026 were SEK 1,484,891, up 25% year-over-year; Q2 net sales were SEK 708,000, up 5% year-over-year.
Operating income for H1 2026 was SEK 1,642,495 (SEK 1,148,573 in H1 2025).
Result after financial items for H1 2026 was SEK -3,038,980 (SEK -4,563,582 in H1 2025); Q2 result was SEK -1,571,111 (SEK -1,859,773 in Q2 2025).
Cash flow from operating activities for H1 2026 was SEK -1,714,039 (SEK -3,814,714 in H1 2025); Q2 cash flow was SEK -1,467,830 (SEK -1,376,673 in Q2 2025).
Earnings per share for H1 2026 was SEK -0,08 (SEK -0,14 in H1 2025); Q2 EPS was SEK -0,04 (SEK -0,06 in Q2 2025).
Outlook and guidance
Sales increases are expected in coming quarters due to ongoing sales activities and product commercialization.
Management believes available liquidity and expected sales will finance operations for the next 12 months, though targeted strategic initiatives may require additional funding.
Latest events from Prebona
- Sales surged 70% year-over-year, with narrowed losses and strong international expansion.PREBON
Q1 2026 - Sales fell in 2025, but new contracts and global expansion set the stage for recovery in 2026.PREBON
Q4 2025 - Q3 2025 marked a turnaround with growth, improved results, and strong international expansion.PREBON
Q3 2025 - Sales declined in Q2, but improved losses and new contracts signal expected recovery ahead.PREBON
Q2 2025 - Sales improved in Q3, but losses persist as new launches and financing support future growth.PREBON
Q3 2024 - Sales and earnings fell, but new products and financing position the company for future growth.PREBON
Q2 2024 - Sales fell sharply in Q1, but HealthCare and AirCare segments showed strong growth potential.PREBON
Q1 2025 - Sales fell but strategic wins and new funding position Prebona for future growth.PREBON
Q4 2024